Published in J Clin Microbiol on July 01, 1993
New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clin Microbiol Rev (2000) 1.75
Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events. J Virol (2000) 1.53
Biphasic viremia and viral gene expression in leukocytes during acute cytomegalovirus infection of mice. J Virol (1994) 1.24
Comparison of three methods for extraction of viral nucleic acids from blood cultures. J Clin Microbiol (1995) 1.14
Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification. J Clin Microbiol (1999) 1.10
Monitoring of cytomegalovirus infection and disease in bone marrow recipients by reverse transcription-PCR and comparison with PCR and blood and urine cultures. J Clin Microbiol (1996) 1.06
Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation. Clin Microbiol Rev (2013) 0.99
Detection of human herpesvirus 6 by reverse transcription-PCR. J Clin Microbiol (1999) 0.99
Value of different assays for detection of human cytomegalovirus (HCMV) in predicting the development of HCMV disease in human immunodeficiency virus-infected patients. J Clin Microbiol (2000) 0.98
Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients. J Clin Microbiol (2000) 0.98
Use of laboratory assays to predict cytomegalovirus disease in renal transplant recipients. J Clin Microbiol (1998) 0.97
Utility of major leukocyte subpopulations for monitoring secondary cytomegalovirus infections in renal-allograft recipients by PCR. J Clin Microbiol (1998) 0.96
Transcription of human herpesvirus-like agent (HHV-8) in Kaposi's sarcoma. J Clin Invest (1996) 0.89
Evaluation of new quantitative assays for diagnosis and monitoring of cytomegalovirus disease in human immunodeficiency virus-positive patients. J Clin Microbiol (1999) 0.89
Quantitation of cytomegalovirus (hCMV) DNA and beta-actin DNA by duplex real-time fluorescence PCR in solid organ (liver) transplant recipients. Med Microbiol Immunol (2003) 0.88
Diagnostic implications of human cytomegalovirus immediate early-1 and pp67 mRNA detection in whole-blood samples from liver transplant patients using nucleic acid sequence-based amplification. J Clin Microbiol (2000) 0.87
No circulating human cytomegalovirus in 14 cases of glioblastoma. Neuro Oncol (2014) 0.75
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77
Avoiding false positives with PCR. Nature (1989) 30.66
Structural analysis of the major immediate early gene of human cytomegalovirus. J Virol (1984) 6.67
Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc Natl Acad Sci U S A (1984) 4.56
Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J Clin Microbiol (1988) 4.05
Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus. J Infect Dis (1988) 3.52
Detection of human cytomegalovirus in clinical specimens by DNA-DNA hybridization. J Infect Dis (1984) 3.10
Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification. J Clin Microbiol (1992) 2.44
Human cytomegalovirus viraemia in HIV-1-seropositive patients at various clinical stages of infection. AIDS (1990) 2.15
Cytomegalovirus DNA detection in sera from patients with active cytomegalovirus infections. J Clin Microbiol (1992) 2.14
Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization. J Infect Dis (1990) 2.08
Cytomegalovirus infection in patients with AIDS. Clin Infect Dis (1992) 1.91
Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients. J Clin Microbiol (1992) 1.74
Correlation between immunofluorescent detection of human cytomegalovirus immediate early antigens in polymorphonuclear leukocytes and viremia. J Infect Dis (1989) 1.59
Identification of the major capsid protein gene of human cytomegalovirus. J Virol (1989) 1.56
Development and clinical significance of a diagnostic assay based on the polymerase chain reaction for detection of human cytomegalovirus DNA in blood samples from immunocompromised patients. J Clin Microbiol (1992) 1.36
Predictive value of cytomegalovirus viraemia for the occurrence of CMV organ involvement in AIDS. J Med Virol (1990) 1.35
Rapid detection of cytomegalovirus DNA in cerebrospinal fluid of AIDS patients with neurologic disorders. J Infect Dis (1992) 1.25
A reverse polymerase chain reaction method for detection of human cytomegalovirus late transcripts in cells infected in vitro. J Virol Methods (1992) 0.90
Detection of mRNA from the immediate early gene of human cytomegalovirus in infected cells by in vitro amplification. Mol Cell Probes (1990) 0.85
Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. Am Rev Respir Dis (1991) 4.74
Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiol Lett (1999) 4.27
Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile. J Clin Microbiol (2000) 2.79
Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect (2001) 2.45
Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol (2000) 2.42
Time to HIV seroconversion after needlestick injury. Lancet (1995) 2.02
Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study. Arch Intern Med (1996) 1.98
A European survey of diagnostic methods and testing protocols for Clostridium difficile. Clin Microbiol Infect (2003) 1.94
Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS. Am J Med (1993) 1.86
Effects of bacterial products on lymphocytes and macrophages: their possible role in natural resistance to listeria infetion in mice. J Immunol (1974) 1.79
Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhea. J Clin Microbiol (1993) 1.77
Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs. Am J Transplant (2009) 1.65
The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD. Aliment Pharmacol Ther (2012) 1.57
Neurological complications of varicella-zoster virus infection in adults with human immunodeficiency virus infection. Scand J Infect Dis (2000) 1.55
Respiratory mechanics studied by forced oscillations during artificial ventilation. Eur Respir J (1993) 1.53
Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile. Microb Ecol (2008) 1.51
Outbreak of tuberculosis in a migrants' shelter, Paris, France, 2002. Int J Tuberc Lung Dis (2005) 1.50
Toxoplasma colitis in the acquired immunodeficiency syndrome. Am J Gastroenterol (1992) 1.46
Occurrence of acute hepatitis A in patients infected with human immunodeficiency virus. Clin Infect Dis (2000) 1.45
Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection. Blood (1997) 1.40
Prophylaxis of anaphylactoid reaction to antituberculous drugs. Ann Pharmacother (1997) 1.39
Multicenter observational study of erlotinib therapy (OBSTAR) for non small-cell lung cancer: a GFPC study. Lung Cancer (2011) 1.39
[Evaluation of preoperative non-invasive ventilation in thoracic surgery for lung cancer: the preOVNI study GFPC 12-01]. Rev Mal Respir (2012) 1.39
Calcification of medial elastic fibers and aortic elasticity. Hypertension (1997) 1.37
Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome. Arch Intern Med (1993) 1.32
Use of the arbitrary primer polymerase chain reaction for investigating an outbreak of Clostridium difficile-associated diarrhea in AIDS patients. Eur J Clin Microbiol Infect Dis (1993) 1.30
Acute hepatitis C in HIV-infected men who have sex with men. HIV Med (2004) 1.26
Rapid detection of cytomegalovirus DNA in cerebrospinal fluid of AIDS patients with neurologic disorders. J Infect Dis (1992) 1.25
Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure. AIDS (2001) 1.24
Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997. Antimicrob Agents Chemother (1999) 1.23
Genomic fingerprinting of Clostridium difficile isolates by using a random amplified polymorphic DNA (RAPD) assay. FEMS Microbiol Lett (1993) 1.23
Acquired immunodeficiency syndrome in France. Lancet (1983) 1.21
Fibroblast-dependent tumorigenicity of cells in nude mice: implication for implantation of metastases. Cancer Res (1986) 1.19
Usefulness of simultaneous detection of toxin A and glutamate dehydrogenase for the diagnosis of Clostridium difficile-associated diseases. Eur J Clin Microbiol Infect Dis (2000) 1.13
Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis (1999) 1.13
Suppression of cellular immunity to Listeria monocytogenes by activated macrophages: mediation by prostaglandins. Infect Immun (1985) 1.12
Expiratory capnography in asthma: evaluation of various shape indices. Eur Respir J (1994) 1.09
Depression by Pseudomonas aeruginosa of two T-cell-mediated responses, anti-Listeria immunity and delayed-type hypersensitivity to sheep erythrocytes. Infect Immun (1982) 1.09
Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication. AIDS (2005) 1.07
High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs. J Antimicrob Chemother (2012) 1.06
Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS. Antimicrob Agents Chemother (1991) 1.06
Monitoring of cytomegalovirus infection and disease in bone marrow recipients by reverse transcription-PCR and comparison with PCR and blood and urine cultures. J Clin Microbiol (1996) 1.06
HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals. Proc Natl Acad Sci U S A (1990) 1.05
Full or partial seroreversion in patients infected by hepatitis C virus. J Infect Dis (1997) 1.03
Emergence of Clostridium difficile toxinotype III, PCR-ribotype 027-associated disease, France, 2006. Euro Surveill (2006) 1.03
Decreased transmission of Enterobacteriaceae with extended-spectrum beta-lactamases in an intensive care unit by nursing reorganization. J Hosp Infect (1995) 1.03
Value of routine stool cultures in hospitalized patients with diarrhea. Eur J Clin Microbiol Infect Dis (1995) 1.02
Investigation of a nosocomial outbreak of Clostridium difficile-associated diarrhoea among AIDS patients by random amplified polymorphic DNA (RAPD) assay. J Hosp Infect (1994) 1.02
Changes in systemic gonadal and adrenal steroids in asymptomatic human immunodeficiency virus-infected men: relationship with the CD4 cell counts. Eur J Endocrinol (1995) 1.01
Characteristics trends, mortality and morbidity in persons newly diagnosed HIV positive during the last decade: the profile of new HIV diagnosed people. Eur J Public Health (2007) 1.01
Resistance to listeriosis in mice that are deficient in the fifth component of complement. Infect Immun (1980) 1.00
Lidocaine down-regulates nuclear factor-kappaB signalling and inhibits cytokine production and T cell proliferation. Clin Exp Immunol (2008) 1.00
Synergy of cefotaxime and fosfomycin against penicillin-resistant pneumococci. J Antimicrob Chemother (1993) 1.00
Direct infection of CD34+ progenitor cells by human cytomegalovirus: evidence for inhibition of hematopoiesis and viral replication. Blood (1996) 0.99
Killing kinetics of imipenem against penicillin-resistant Streptococcus pneumoniae. J Antimicrob Chemother (1994) 0.97
Clostridium difficile-associated diarrhea in HIV-infected patients: epidemiology and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.96
Early detection of hepatitis C virus infection by use of a new combined antigen-antibody detection assay: potential use for high-risk individuals. J Clin Microbiol (2006) 0.95
Endotoxemia and bacteremia in patients with sepsis syndrome in the intensive care unit. Chest (1994) 0.95
[NADIS 2000, development of an electronic medical record for patients infected by HIV, HBV and HCV]. Presse Med (2003) 0.92
Nosocomial Serratia marcescens infections associated with extrinsic contamination of a liquid nonmedicated soap. Infect Control Hosp Epidemiol (2000) 0.92
Pseudomonas aeruginosa infection in human immunodeficiency virus infected patients. J Infect (1999) 0.91
Respiratory input and transfer mechanical impedances in patients with chronic obstructive pulmonary disease. Eur Respir J (1990) 0.91
Subcutaneous granuloma caused by Phialophora richardsiae: case report and review of the literature. Mycoses (1989) 0.91
A reverse polymerase chain reaction method for detection of human cytomegalovirus late transcripts in cells infected in vitro. J Virol Methods (1992) 0.90
Efficacy of zidovudine in preventing relapses of Salmonella bacteremia in AIDS. J Infect Dis (1991) 0.90
Immunoglobulins in the intestinal content of the human fetus with special reference to IgA. Eur J Immunol (1973) 0.89
Comparison of enterotoxin production, cytotoxin production, serogrouping, and antimicrobial susceptibilities of Clostridium difficile strains isolated from AIDS and human immunodeficiency virus-negative patients. J Clin Microbiol (1993) 0.89
High dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas and solid tumors. A study of 23 patients. Eur J Cancer (1981) 0.89
Regeneration of the connective tissue attachment on surgically exposed roots using a fibrin-fibronectin adhesive system. An experimental on the baboon (Papio ursinus). J Periodontal Res (1987) 0.89
Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study. Hepatology (1997) 0.88
Helicobacter pylori: has it a part in the lesion of the gastroesophageal reflux? J Infect Dis (1990) 0.88
Respiratory tissue properties derived from flow transfer function in healthy humans. J Appl Physiol (1985) (1997) 0.88
Respiratory mechanics studied by multiple linear regression in unsedated ventilated patients. Eur Respir J (1992) 0.88
AIDS-related primary pulmonary lymphoma. Am J Respir Crit Care Med (1998) 0.88
Impairment of circulating lactoferrin in HIV-1 infection. Cell Mol Biol (Noisy-le-grand) (1995) 0.87
Pulmonary toxoplasmosis in HIV-infected patients: usefulness of polymerase chain reaction and cell culture. Eur Respir J (1995) 0.86
Pseudo-outbreak of Mycobacterium gordonae associated with water from refrigerated fountains. J Hosp Infect (2001) 0.86
Impact of a multidisciplinary approach to the control of antibiotic prescription in a general hospital. J Hosp Infect (2003) 0.86
Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis. Proc Natl Acad Sci U S A (1993) 0.86
Detection of human herpesvirus 8 DNA sequences before the appearance of Kaposi's sarcoma in human immunodeficiency virus (HIV)-positive subjects with a known date of HIV seroconversion. J Infect Dis (1996) 0.86
Possible importation and subsequent cross-transmission of OXA-48-producing Klebsiella pneumoniae, France, 2010. Euro Surveill (2010) 0.85
Correlation between HIV provirus burden and in utero transmission. AIDS (1993) 0.85
The role of mucus sol phase in clearance by simulated cough. Biorheology (1989) 0.85
Upper airway artifact in respiratory impedance measurements. Am Rev Respir Dis (1985) 0.85
Spinability of bronchial mucus. Relationship with viscoelasticity and mucous transport properties. Biorheology (1983) 0.85